Research targets treatments for Marfan syndrome, aortic dissections

A blood test that identifies enlarged aortas before they rupture shows promise for patients with Marfan syndrome and others with risk factors for the deadly condition, according to a study led by Dr. Hal Dietz of Johns Hopkins University, who has been studying Marfan for decades. Dietz and his team also discovered that a blood pressure medication, losartan, blocks the protein involved in Marfan and seems to reverse some of its effects and stem abnormal growth of the aorta.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ